January 14, 2017 /
An MS Patients Story
Click here to receive MS news via e-mail

By Devin Garlit—December 22, 2016
I’ve been writing about my journey with multiple sclerosis for a while now. I’ve discussed a wide range of issues that I’ve dealt with over my many years with the disease. I have, however, held off on devoting an entire article to one of my worst symptoms until now. While I’ve made mention of it before, chronic MS-related pain is a symptom that I encounter every single day. It’s one that is hard to find relief from and it’s one that I know has a profound impact on who I am. For good and for bad, chronic pain can change you.
When I was diagnosed some 17 years ago, I had no idea that pain could even be an issue with MS. Despite having a grandfather with MS, I found I was naive about a lot of the issues that can come with MS. As far as pain was concerned, I figured that most pain would come from the number of falls I’d take. I also didn’t start out with pain as a symptom, not until about 14 years diagnosed did I really start to suffer from it. And suffer I have; I never expected the kind of intense pain that seemed to suddenly appear out of nowhere. It’s as if someone has a voodoo doll of me somewhere and is really working it over with an assortment of torture devices.
I keep saying “pain” without really explaining it; I feel many of my colleagues have done a great job talking about pain in the past, so I don’t want to simply rehash what’s been said. I’ve also talked before about my issues sleeping with pain (what I like to call Painsomnia). With MS, pain can really encompass a number of things: Trigeminal Neuralgia (a stabbing pain in the face), the MS Hug (a tight, constricting pain in stomach and sometimes chest area), Lhermitte’s sign (an electric shock type sensation up your spine when you tilt your head down), Spasticity, Paresthesia (numbness and tingling), and Dysesthesia (burning, stabbing, or tearing pain). Now that we’ve gotten some official and crazy looking words out of the way, I’ll tell you that my personal experience deals mostly with the last three of those. I’ve already done a full post on spasticity, so I’ll try not to go into too much more about that. In addition to that spasticity, I am plagued by numbness/tingling sensations and brutal burning and stabbing pain.
Read complete article by clicking here
MS Views and News
Providing educational information, resources and services for those affected by MS
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- People Wait an Average of 50 Days to See a Neurologist, and People with MS Wait Even Longer: What Can We Do to Improve Access to MS Care?
- Key Findings on GLP-1 Use in MS
- Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
- Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
- This Blood Test Tracks MS Activity? (Octave Explained)
- Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
- Will Medicare Pay for a Mobility Scooter?
- Vagus nerve stimulation (VNS)
- Vitamin D Deficiency in Adults: Symptoms, Treatments, and Related Health Conditions
- How to Get Through an MRI if You’re Claustrophobic
- How MS Can Affect Your Oral Health
- Signs of multiple sclerosis show up in blood years before symptoms, study finds
- MS patients less likely to have Alzheimer’s, study finds
- APOE4 gene variant linked to greater nerve damage in MS: Study
- High Epstein-Barr antibody levels over time may aid MS diagnosis
- Stopping Ocrevus in stable MS doesn’t seem to raise 2-year risk, study finds
- Online Survey: Stress and MS – from the National MS Society
- High-Altitude Gene Helps Heal Myelin Damage
- Talking Biosimilars – Unlocking Patient access through coordinated action
- Beyond One Drug: What the Tolebrutinib Decision Teaches Us About Progressive MS Trials.
